Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZLAB · against 367 other Healthcare companies of similar size
Ranked #245 of 368 · scores higher than 34% of peers · safety percentile 37
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)35 peers with a safety percentile of 30–39, including ZLAB · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ZLAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 352 reported | 0.42× | 0.22× | 34% | 33% | |
| BetaLower is better · 351 reported | 0.83 | 0.57 | 35% | 33% | |
| Current ratioHigher is better · 355 reported | 2.13× | 2.89× | 40% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 2.6B USD | 100 | 43 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 1.8B USD | 99 | 42 | |
| 5 | 2.2B USD | 99 | 48 | |
| 241 | 10.8B SAR (≈$2.9B) | 38 | 68 | |
| 242 | 19.0B CNY (≈$2.7B) | 38 | 55 | |
| 243 | 1.6B USD | 37 | 33 | |
| 244 | 1.9B USD | 37 | 18 | |
| 245 | 2.5B USD | 37 | 31 | |
| 246 | 22.1B CNY (≈$3.1B) | 36 | 49 | |
| 247 | 10.4B CNY (≈$1.5B) | 36 | 42 | |
| 248 | 1.86T KRW (≈$1.3B) | 36 | 43 | |
| 249 | 4.6B USD | 36 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score